EquitiesAmerica.com
Educational content — not investment advice

DaVita Inc.

DVANYQHealthcare
Visit Website

Data as of April 18, 2026

Key Metrics

Market Cap

$9.89B

P/E Ratio

15.55

P/B Ratio

-15.57

Dividend Yield

Return on Equity

0.65%

Debt / Equity

1111.35

Insider Ownership

50.44%

Institutional Own.

52.82%

Employees

78,000

Sector & Industry

Sector

Healthcare

Industry

Medical Care Facilities

About DaVita Inc.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Ownership Snapshot

Insider50.44%
Institutional52.82%
Public / Other0.00%

Source: Yahoo Finance / SEC filings. For full details, see the Holdings page.

Explore More

Disclaimer: All data on this page is historical and sourced from publicly available databases including SEC EDGAR and Yahoo Finance. EquitiesAmerica.com is an educational publisher and does not provide personalized investment guidance, securities analysis, or trading recommendations. Past data does not predict future results. Please consult a registered investment professional before making any financial decision. Read full disclaimer.